AbCellera
AbCellera Raises $555M in Series B
Quick Facts
AbCellera Raises $555M in Series B
AbCellera has successfully raised $555M in a Series B at a $5.7B valuation led by Peter Thiel, Eli Lilly, Fast Forward Innovations, DCVC Bio.
Company Overview
AbCellera is a Biotech company headquartered in 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada, founded in 2012 with 400+ employees.
Antibody discovery platform
Fundraising Details
- Amount Raised: $555M
- Round Type: Series B
- Valuation: $5.7B
- Date: 2024-06-12
- Investors: Peter Thiel, Eli Lilly, Fast Forward Innovations, DCVC Bio
About AbCellera
Antibody discovery platform The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
- Founded: 2012
- Team Size: 400+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in AbCellera's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. AbCellera's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $5.7B valuation marks an important milestone for AbCellera, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, AbCellera is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-06-12. For more information about AbCellera, visit their headquarters at 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
About the Author
Related Company Reports
Harvey AI Raises $160 million in Series F
Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.
7AI Raises $130 million in Series A
7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.
TRIANA Biomedicines Raises $120 million in Series B
TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.